NFE2L2 and diabetes mellitus: Sodium butyrate, a known activator of Nrf2, ameliorates diabetes-induced renal oxidative damage, pathological changes, and dysfunction [11], which suggests that Nrf2 has a key role in the pathogenesis of DN.